MacroGenics Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in Gastric or Gastroesophageal Junction Cancer

    NEXT STORY
    Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results
    PREV STORY
    Global $4.2Bn Medical Refrigerators Markets to 2024 – Blood Banks Projected to Lead the Market, in Terms of Both Value & Volume
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results

    -Obtained Approvals of CTAs in Multiple Countries for CTX001 in β-thalassemia and SCD--Initiation of ...

    author_avatar
    NASDAQ Market News

    Point-of-Care/Rapid Diagnostics Market by Testing, Platform, Mode & End-User – Global Forecast to 2022

    Dublin, Feb. 27, 2018 (GLOBE NEWSWIRE) -- The "Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, ...

    author_avatar
    NASDAQ Market News

    Revolution Medicines to Present Interim Data at ENA 2020 from Phase 1b/2 Clinical Trial Combining RMC-4630 with Cobimetinib for RAS-Addicted Solid Tumors

    author_avatar
    NASDAQ Market News